Alkeus Pharmaceuticals, Inc., a biopharmaceutical company dedicated to preserving the sight of individuals impacted by ...

China is adapting its Life Sciences policy to bolster innovation and data transparency. Big Pharma is taking note.

After prolonged negotiations, Singapore government-owned investment firm Temasek is nearing a deal to acquire a 10 per cent ...

Blackstone-led investor group to purchase majority stake in Citrin Cooperman, boosting firm's enterprise value to over $2B.

Insignia manages A$319 billion across its sprawling portfolio. That includes billions in retirement savings across a range of ...

As aviation mysteries go, the case of Virgin Australia CEO Jayne Hrdlicka is not in the same league as the disappearance of MH370, but it remains a source of widespread industry intrigue.

Also in today’s newsletter, Canada’s Trudeau announces resignation, and Tencent added to Pentagon list of companies working with China’s military ...

U.S. private equity fund KKR said it has asked Fuji Soft to file for an injuction in court to stop what it said was Bain ...

SYDNEY: Insignia Financial shares shot up to a three-year high yesterday after it revealed a A$2.87bil (US$1.78bil) takeover ...

Medical-device maker Stryker on Monday agreed to acquire Inari Medical , which makes devices that treat patients with venous diseases, in an all-cash deal worth $4.9 billion.

The latest offer is contingent on satisfactory due diligence, a unanimous board recommendation, and regulatory approvals.